Selection of Surgical Technique in Rectal Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta

About this trial

Currently, there is no prediction scale available to identify patients with rectal neoplasms as technically complex in the middle and lower thirds; that is, those who are at high risk of affected circumferential margins and low quality of the mesorectum. The application of a predictive model that allows preoperative identification of the group of patients in whom optimal results in mesorectal quality and circumferential margin are less likely to be obtained through laparoscopic or minimally invasive surgery would enable the selection of patients who will require and justify all efforts and healthcare resources to improve surgical outcomes.

Therefore, the investigators aim to create a predictive model to identify these patients, allowing the discrimination of which patients will benefit from different techniques, or even which ones would be opportune to initially consider an open approach.

Eligibility criteria

Qualifiers

Scheduled surgery for anterior resection of the rectum meeting oncological criteria with mesorectal excision.

Age ≥ 18 years.

Histology of adenocarcinoma with or without neoadjuvant chemotherapy or chemoradiotherapy.

Initial stage T1-T4a. Any N. Any M.

Disqualifiers

Colorectal tumor with histology different from adenocarcinoma.

Synchronous colon tumor.

Benign pathology or adenoma.

Tis.

Trial design

Treatments tested in this trial

  • Data collection

Treatment groups

333 Participants
are divided into 1 treatment group